Global Drug Discovery and Pharmacology Congress - 2027

Advancing Therapeutic Precision: A Focus on Clinical Pharmacology and Molecular Drug Discovery

The Global Drug Delivery & Pharmacy Congress 2027 (GDDPC 2027) will be held on September 24–25, 2027, in Kolkata, West Bengal. The congress convenes to address the critical nexus between high-throughput drug discovery and evidence-based clinical pharmacology. As the pharmaceutical industry pivots toward precision medicine, GDDPC 2027 provides a rigorous technical forum for the exchange of data on target validation, pharmacokinetics, and the integration of novel delivery modalities into clinical practice.

The congress prioritizes the dissemination of peer-reviewed research, emphasizing the transition of drug candidates from preclinical identification to Phase I/II clinical trials. We provide an environment for discourse on optimizing drug metabolism, managing pharmacodynamic variability, and implementing advanced drug delivery architectures that mitigate systemic toxicity while enhancing therapeutic efficacy.

Scientific Focus Areas:

1. Molecular Drug Discovery: Exploring novel target identification, ligand-protein interactions, and the application of structure-based drug design (SBDD) in addressing complex disease pathologies.
2. Pharmacodynamics & Pharmacokinetics (PK/PD): Analyzing the dose-response relationship, systemic absorption, distribution, and metabolic transformation of nextgeneration therapeutic agents.
3. Advanced Delivery Systems: Evaluating the clinical utility of nano-formulations, site-specific drug delivery, and modified-release mechanisms designed to improve patient-centric outcomes.
4. Translational Pharmacology: Bridging the gap between in vitro discovery models and clinical efficacy by addressing drug safety, bioavailability, and translational biomarkers

Targeted Clinical & Scientific Engagement:

GDDPC 2027 is structured for subject matter experts engaged in the clinical and research phases of pharmaceutical development, including:

• Clinical Pharmacologists & Medical Scientists focused on therapeutic drug monitoring and clinical safety assessments.
• Drug Discovery Leads specializing in medicinal chemistry, high-throughput screening, and lead optimization.
• Regulatory & Clinical Research Professionals managing the transition of investigational new drugs (INDs) through the clinical pipeline.
• Translational Research Investigators dedicated to bridging experimental discovery with bedside clinical application.

GDDPC 2027 serves as an essential platform for professionals committed to the scientific advancement of drug discovery and the systematic optimization of clinical pharmacological standards. We invite you to join this elite assembly in Kolkata as we define the next generation of therapeutic intervention.